ArticleNMR in biomedicine2026
Standard Model Imaging in the Brain and Spinal Cord of MS Patients: Initial Assessment and Comparison to Diffusion Tensor Imaging.
Article in NMR in biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Multiple sclerosis (MS) pathology manifests across the central nervous system (CNS), yet magnetic resonance imaging (MRI) studies frequently assess the brain and spinal cord (SC) in isolation. It remains unclear whether microstructural injury in normal-appearing white matter (NAWM) and lesions manifests identically across these distinct anatomical environments or if advanced biophysical models offer diagnostic advantages over standard diffusion techniques. We performed a comprehensive 3T MRI protocol with same-session brain and cervical SC imaging on 34 persons with relapsing-remitting MS (pwRRMS) and 36 healthy controls (HCs). We focused on diffusion frameworks (diffusion tensor imaging [DTI], standard model imaging with free water [SMIfw]) to quantify and compare microstructural integrity between the brain and cervical SC for the first time. Specifically, we assessed the feasibility of SMI for clinical implementation in terms of sensitivity (contrast between lesions and NAWM in pwRRMS) and reliability (HC reproducibility). Our findings indicate that both simple (DTI) and advanced (SMI) models are sensitive to MS-related microstructural changes, but the utility varied by region: notably, SMI-derived neurite density fraction (f) emerged as a robust marker of MS pathology in both the brain and SC, while DTI metrics like fractional anisotropy (FA) and radial diffusivity (RD) showed comparable sensitivity exclusively in the brain. Though axonal loss appears to be a global feature detectable even in early-stage disease, the inflammatory or edematous environment of lesions differs fundamentally between the brain and SC. Taken together, these findings demonstrate the utility of SMI for comprehensive CNS assessment and support its potential for future usage in clinical trials and improved disease monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.